217 related articles for article (PubMed ID: 27614661)
1. Salvage high-dose-rate brachytherapy for isolated vaginal recurrence of endometrial cancer.
Baek S; Isohashi F; Yamaguchi H; Mabuchi S; Yoshida K; Kotsuma T; Yamazaki H; Tanaka E; Sumida I; Tamari K; Otani K; Seo Y; Suzuki O; Yoshioka Y; Kimura T; Ogawa K
Brachytherapy; 2016; 15(6):812-816. PubMed ID: 27614661
[TBL] [Abstract][Full Text] [Related]
2. Salvage high-dose-rate brachytherapy and external beam radiotherapy for isolated vaginal recurrences of endometrial cancer with no prior adjuvant therapy.
Chapman CH; Maghsoudi K; Littell RD; Chen LM; Hsu IC
Brachytherapy; 2017; 16(6):1152-1158. PubMed ID: 28802913
[TBL] [Abstract][Full Text] [Related]
3. Definitive salvage for vaginal recurrence of endometrial cancer: the impact of modern intensity-modulated-radiotherapy with image-based HDR brachytherapy and the interplay of the PORTEC 1 risk stratification.
Vargo JA; Kim H; Houser CJ; Berhane H; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Huang M; Courtney-Brooks M; Beriwal S
Radiother Oncol; 2014 Oct; 113(1):126-31. PubMed ID: 25241996
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes following 3D image-guided brachytherapy for vaginal recurrence of endometrial cancer.
Lee LJ; Damato AL; Viswanathan AN
Gynecol Oncol; 2013 Dec; 131(3):586-92. PubMed ID: 24029418
[TBL] [Abstract][Full Text] [Related]
5. Outcomes and toxicity after salvage radiotherapy for vaginal relapse of endometrial cancer.
Sapienza LG; Ning MS; de la Pena R; McNew LK; Jhingran A; Georgeon L; Rasool N; Gomes MJL; Abu-Isa E; Baiocchi G
Int J Gynecol Cancer; 2020 Oct; 30(10):1535-1541. PubMed ID: 32376738
[TBL] [Abstract][Full Text] [Related]
6. Salvage treatment with high-dose-rate brachytherapy for isolated vaginal endometrial cancer recurrence.
Petignat P; Jolicoeur M; Alobaid A; Drouin P; Gauthier P; Provencher D; Donath D; Van Nguyen T
Gynecol Oncol; 2006 Jun; 101(3):445-9. PubMed ID: 16386785
[TBL] [Abstract][Full Text] [Related]
7. Definitive radiotherapy in the management of isolated vaginal recurrences of endometrial cancer.
Lin LL; Grigsby PW; Powell MA; Mutch DG
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):500-4. PubMed ID: 16168841
[TBL] [Abstract][Full Text] [Related]
8. Outcomes after definitive re-irradiation with 3D brachytherapy with or without external beam radiation therapy for vaginal recurrence of endometrial cancer.
Ling DC; Vargo JA; Glaser SM; Kim H; Beriwal S
Gynecol Oncol; 2019 Mar; 152(3):581-586. PubMed ID: 30600093
[TBL] [Abstract][Full Text] [Related]
9. MR- versus CT-based high-dose-rate interstitial brachytherapy for vaginal recurrence of endometrial cancer.
Kamran SC; Manuel MM; Catalano P; Cho L; Damato AL; Lee LJ; Schmidt EJ; Viswanathan AN
Brachytherapy; 2017; 16(6):1159-1168. PubMed ID: 28823395
[TBL] [Abstract][Full Text] [Related]
10. Definitive radiotherapy for patients with isolated vaginal recurrence of endometrial carcinoma after hysterectomy.
Jhingran A; Burke TW; Eifel PJ
Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1366-72. PubMed ID: 12873682
[TBL] [Abstract][Full Text] [Related]
11. Treatment of vaginal recurrences in endometrial carcinoma by high-dose-rate brachytherapy.
Sorbe B; Söderström K
Anticancer Res; 2013 Jan; 33(1):241-7. PubMed ID: 23267151
[TBL] [Abstract][Full Text] [Related]
12. Perineal template interstitial brachytherapy salvage for recurrent endometrial adenocarcinoma metastatic to the vagina.
Nag S; Martínez-Monge R; Copeland LJ; Vacarello L; Lewandowski GS
Gynecol Oncol; 1997 Jul; 66(1):16-9. PubMed ID: 9234914
[TBL] [Abstract][Full Text] [Related]
13. High-dose-rate interstitial brachytherapy for the treatment of high-volume locally recurrent endometrial carcinoma.
Huang K; D'Souza D; Patil N; Velker V; Leung E; Stitt L; Whiston F; Sugimoto A; McGee J; Prefontaine M
Brachytherapy; 2016; 15(5):543-8. PubMed ID: 27475479
[TBL] [Abstract][Full Text] [Related]
14. High-dose-rate interstitial brachytherapy for vaginal endometrial cancer recurrence after prior surgery and radiotherapy.
Chapman CH; Cunha AJ; Littell RD; Chen LM; Hsu IC
Brachytherapy; 2021; 20(3):536-542. PubMed ID: 33549517
[TBL] [Abstract][Full Text] [Related]
15. Postoperative vaginal brachytherapy alone is the treatment of choice for grade 1-2, stage IC endometrial cancer.
Cengiz M; Singh AK; Grigsby PW
Int J Gynecol Cancer; 2005; 15(5):926-31. PubMed ID: 16174247
[TBL] [Abstract][Full Text] [Related]
16. Image-based multichannel vaginal cylinder brachytherapy for vaginal cancer.
Vargo JA; Kim H; Houser CJ; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Huang M; Courtney-Brooks M; Beriwal S
Brachytherapy; 2015; 14(1):9-15. PubMed ID: 25456026
[TBL] [Abstract][Full Text] [Related]
17. Do vaginal recurrence rates differ among adjuvant vaginal brachytherapy regimens in early-stage endometrial cancer?
Ager BJ; Francis SR; Do OA; Huang YJ; Soisson AP; Dodson MK; Werner TL; Sause WT; Grant JD; Gaffney DK
Brachytherapy; 2019; 18(4):453-461. PubMed ID: 31005603
[TBL] [Abstract][Full Text] [Related]
18. Isolated vaginal recurrences of endometrial carcinoma.
Morgan JD; Reddy S; Sarin P; Yordan E; DeGeest K; Hendrickson FR
Radiology; 1993 Nov; 189(2):609-13. PubMed ID: 8210396
[TBL] [Abstract][Full Text] [Related]
19. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
Alektiar KM; Venkatraman E; Chi DS; Barakat RR
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
[TBL] [Abstract][Full Text] [Related]
20. Interstitial brachytherapy for salvage treatment of vaginal recurrences in previously unirradiated endometrial cancer patients.
Nag S; Yacoub S; Copeland LJ; Fowler JM
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(4):1153-9. PubMed ID: 12419443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
